Showing results (791-800 of 1,182) with videos related to

Sort By:
Pageof 119
Applied Health Economics and Health Policy|April 29, 2019
The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health AdministrationRisha Gidwani-Marszowski, Douglas K Owens, Jeanie Lo, et al.
Applied Health Economics and Health Policy|May 17, 2019
Access and Affordability of Medicines in Malaysia: Need for a National Pricing PolicyShui Ling Wong, Saliza Ibrahim, Norazlin Abdul Kadir, et al.
Applied Health Economics and Health Policy|August 21, 2018
SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology GuidanceTom Macmillan, Mark Pennington, Jennifer A Summers, et al.
Applied Health Economics and Health Policy|September 5, 2018
Cost-Effectiveness of Scaling Up Modern Family Planning Interventions in Low- and Middle-Income Countries: An Economic Modeling Analysis in Indonesia and UgandaNeily Zakiyah, A D I van Asselt, D Setiawan, et al.
Applied Health Economics and Health Policy|June 7, 2019
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid LeukemiaCarsten Hirt, Sergio Iannazzo, Silvia Chiroli, et al.
Applied Health Economics and Health Policy|June 8, 2019
Mental health: A Particular Challenge Confronting Policy Makers and EconomistsPeter Zweifel
Applied Health Economics and Health Policy|May 18, 2019
Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision MakersSimon Walker, Susan Griffin, Miqdad Asaria, et al.
Applied Health Economics and Health Policy|March 14, 2022
How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15Stephen Martin, Karl Claxton, James Lomas, et al.
Applied Health Economics and Health Policy|March 28, 2022
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian SettingSara Stafford, Peter G Bech, Adam Fridhammar, et al.
Applied Health Economics and Health Policy|April 4, 2022
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future OptionsRositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, et al.
Pageof 119